DRAGON PHARMACEUTICALS INC
SB-2/A, EX-10, 2000-11-30
PHARMACEUTICAL PREPARATIONS
Previous: DRAGON PHARMACEUTICALS INC, SB-2/A, 2000-11-30
Next: DRAGON PHARMACEUTICALS INC, SB-2/A, EX-23, 2000-11-30




    Amendment to the China-Foreign Joint Venture Agreement (the "Agreement")
                               Dated 27 July 1999

     BETWEEN:

     The Nanjing Yiyao Group Company Limited (Party A)

     AND:

     Allwin Newtech Ltd. (Party B)

Article 19 of the Agreement is hereby amended to read as follows:

"The Board of Directors  shall hold meetings at least once a year. This shall be
called  and  held by the  Managing  Director.  Subject  to a motion  carried  by
two-fifths of the  directors,  the Managing  Director may call an  extraordinary
meeting. The minutes of the meetings shall be filed and kept. In principal,  the
meetings shall be held at the place where the  Joint-Venture  Company is but may
be  decided by the Board of  Directors  to be held  elsewhere.  The quorum for a
directors meeting shall be three-fifths of all the directors. The resolutions of
the Board of Directors  shall come in the written form.  The  resolutions of the
Board of Directors  shall have binding force.  Those directors who are unable to
attend a directors  meeting may sign proxies to appoint other directors to carry
out their duties."

All other  articles shall remain as written in the original  Agremeent  dated 27
July 1999.

The  Amendment is drawn up on 24 November  2000 and is signed by the  authorized
representatives of both Party A and Party B.

Party A:  The Nanjing Yiyao Group Company Limited


                                                                        [seal]
Jian Mao Li

Authorized Signature


Party B:  Allwin Newtech Ltd.


                                                                        [seal]
Longbin Liu

Authorized Signature



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission